- Quantifying AOPs for Predictive Dev Tox: DARTable Genome and PBPK-Driven NAMs for Regulatory De-risking
-
Hemisfair Ballroom C3‚ Convention Center
Chair: Shermaine Mitchell-Ryan, HESI
Co-Chair: Richard Currie, Syngenta, United Kingdom
Primary Endorser: Reproductive and Developmental Toxicology Specialty Section
Endorser(s): Regulatory and Safety Evaluation Specialty Section
Endorser(s): Risk Assessment Specialty Section
New Approach Methodologies (NAMs) offer opportunities to quantify adverse outcome pathway (AOP) thresholds. NAMs were used to strengthen developmental toxicity assessment by integrating mechanistic insights with predictive exposure information. The Health and Environmental Sciences Institute (HESI) DARTable Genome initiative applies a combinatorial NAMs framework to link in vitro potency and pathway-level data to systemic exposure metrics. While the DARTable Genome principles can be applied to other substances, retinoids will be used here as case study.Retinoic acid and related retinoid compounds were selected for initial evaluation because they are well studied and mechanistically informative, yet our review revealed that key pharmacokinetic parameters were missing or inconsistent in publicly accessible datasets. These gaps limited the ability to interpret potency relative to internal exposure. To address this challenge, a similarity basedphysiologically based pharmacokinetic (PBPK) modeling strategy was developed using the SimulationsPlus software. The model for target chemicals was fully parameterized based on the Next-Generation Risk Assessment (NGRA)principles and without using any in vivo data in its construction. PBPK modeling has been used in toxicology to support in vitro to in vivo extrapolation and to estimate internal exposures when empirical data are limited, including for developmental and early life assessments. The resulting workflow enabled interpolation of missing kinetic values, comparison of model performance, and transparent selection of model configurations for potency contextualization. Integrating PBPK with the DARTable Genome provides a quantitative and biologically grounded approach for advancing predictive developmental toxicology and offers opportunities to use NAMs for regulatory decision making.Session and Activity Type
Enter Note
Go to previous page in this tab
Event
